Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
313.26B | 315.42B | 299.60B | 275.06B | 253.39B | 283.75B | Gross Profit |
114.83B | 114.78B | 108.96B | 97.93B | 95.00B | 126.76B | EBIT |
20.50B | 20.00B | 19.47B | 16.63B | 19.23B | 19.40B | EBITDA |
29.53B | 34.36B | 41.08B | 33.47B | 30.21B | 31.14B | Net Income Common Stockholders |
13.39B | 12.49B | 17.58B | 13.67B | 13.96B | 8.75B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
79.64B | 98.48B | 80.76B | 70.75B | 81.01B | 88.42B | Total Assets |
429.65B | 435.07B | 431.60B | 396.73B | 382.02B | 369.15B | Total Debt |
13.72B | 20.29B | 12.33B | 10.65B | 5.86B | 5.41B | Net Debt |
-60.42B | -77.20B | -68.44B | -54.10B | -69.14B | -73.50B | Total Liabilities |
110.47B | 112.19B | 109.99B | 95.39B | 83.45B | 81.86B | Stockholders Equity |
289.82B | 292.82B | 292.21B | 272.29B | 268.97B | 258.14B |
Cash Flow | Free Cash Flow | ||||
0.00 | 13.41B | 12.90B | 4.32B | 2.37B | 12.19B | Operating Cash Flow |
0.00 | 26.57B | 25.57B | 19.48B | 16.14B | 23.18B | Investing Cash Flow |
0.00 | -12.28B | -2.30B | -21.47B | -10.40B | -8.56B | Financing Cash Flow |
0.00 | -9.06B | -7.38B | -12.74B | -10.07B | -6.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥275.25B | 21.42 | 4.20% | 1.70% | 5.28% | -26.74% | |
65 Neutral | $8.92B | 15.03 | 4.68% | 6.11% | 3.59% | -2.49% | |
€1.82B | 51.66 | 2.04% | 1.99% | ― | ― | ||
72 Outperform | ¥262.15B | 21.42 | 3.03% | 3.47% | -15.46% | ||
68 Neutral | ¥261.77B | 16.62 | 1.94% | 25.63% | -24.35% | ||
63 Neutral | ¥291.22B | 50.82 | 2.74% | 2.58% | -90.55% | ||
46 Neutral | ¥252.08B | 113.05 | 1.77% | 18.99% | -65.81% |